Observation and treatment groups at 12 weeks, during delivery, 12 weeks after delivery abnormal liver function was not statistically significant (X2 respectively 0.007,0.162,0.074, P> 0.05).
The difference between the observation group and the treatment group was no statistically significant compared with liver function abnormality at 12 weeks of treatment, during delivery and 12 weeks after delivery (X2 was 0.007, 0.162, 0.074, p value s/05).
There was no significant difference in liver function between the observation group and the treatment group at 12 weeks of treatment, delivery and 12 weeks after delivery (x2 was 0.007, 0.162 and 0.074 respectively, P > 0.05).